The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September.
In this article we are going to use hedge fund sentiment as a tool and determine whether Celldex Therapeutics, Inc. (NASDAQ:CLDX) is a good investment right now.
The 800+ hedge funds and famous money managers tracked by Insider Monkey have already compiled and submitted their 13F filings for the second quarter, which unveil their equity positions as of September.